Reportstack

PharmaPoint: Obesity - Italy Drug Forecast and Market Analysis to 2022

 
Repost This

Naperville, IL -- (SBWIRE) -- 02/24/2014 -- Reportstack, provider of premium market research reports announces the addition of PharmaPoint: Obesity - Italy Drug Forecast and Market Analysis to 2022 market report to its offering
PharmaPoint: Obesity - Italy Drug Forecast and Market Analysis to 2022

Summary

After a more than decade long dormancy, the Obesity market is undergoing a revival with the advent of several novel therapies that will lend considerable visibility to this indication space. This includes the use of combination therapies that simultaneously target multiple pathways and regulate appetite control, as well as novel molecular entities with new mechanisms of action. Due to this growing pipeline of late-stage drugs, this market is expected to experience substantial growth over the next decade.

The Italian obesity drug market was valued at approximately $31m in 2012. The projected drivers of sales growth include the launch of Victoza, which was originally indicated for type 2 diabetes treatment, but will eventually available for the treatment of the obese population and the rise in obesity-related comorbidities. For the treatment of overweight and obesity, the Italian pharmaceutical market currently has only Xenical and its generic, the use of which is on the decline.

Scope

- Overview of Obesity including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
- Detailed information on the key drugs in Italy including product description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for the top drugs in Italy from 2012-2022.
- Analysis of the impact of key events as well the drivers and restraints affecting the Italy Obesity market.

Reasons to buy

- Understand and capitalize by identifying products that are most likely to ensure a robust return.
- Stay ahead of the competition by understanding the changing competitive landscape for Obesity.
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential.
- Make more informed business decisions from insightful and in-depth analysis of drug performance.
- Obtain sales forecast for drugs from 2012-2022 in Italy.

To view the table of contents for this market research report please visit
http://www.reportstack.com/product/150637/pharmapoint-obesity-italy-drug-forecast-and-market-analysis-to-2022.html
Contact:
Roger Campbell
contactus@reportstack.com
Naperville
Illinois
United States
Ph: 888-789-6604
###